Mirati Therapeutics | Capitalisation Boursière

Market Capitalization Changement Date
Agios Pharmaceuticals USD 1.25B 135M 2023-12
Alnylam Pharmaceuticals USD 24.02B 1.88B 2023-12
Amgen USD 154.14B 10.38B 2023-12
Astellas Pharma JPY 3.04T 709.27B 2023-12
AstraZeneca GBP 164.29B 7.78B 2023-12
Bayer EUR 33.04B 11.61B 2023-12
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Bluebird Bio USD 325M 25M 2023-09
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Eisai JPY 2.09T 376.18B 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Exelixis USD 7.46B 503M 2023-12
Gilead Sciences USD 100.94B 7.57B 2023-12
GlaxoSmithKline GBP 59.68B 1.42B 2023-12
Incyte USD 12.89B 1.18B 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Merck USD 314.33B 38.07B 2024-03
Moderna USD 40.08B 2.16B 2024-03
Nektar Therapeutics USD 113M 4M 2023-09
Novartis CHF 193.29B 20.5B 2023-12
Pfizer USD 155.51B 7.05B 2024-03
Roche Holding CHF 199.67B 23.81B 2023-12
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Takeda JPY 6.42T 928.65B 2023-12
Ultragenyx Pharmaceutical USD 3.77B 153M 2024-03



Mirati Therapeutics Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.